Biotechniques-in-Industries
Local delivery of medicine has become another to beat many aspect effects of typical drug
administration ways. Attributable to their novel properties, nanomaterials for controlled drug unleash have shown monumental potential within the treatment of cancer. within the gift work a chemotherapeutical agent, antimetabolite (MTX) was encapsulated into a sol-gel SiO2 matrix, as a reservoir for native controlled unleash within the treatment of a solid
brain tumour like
brain tumor Multiforme (GBM) in Associate in
Nursing animal model. so as to check interactions between the drug and also the SiO2, many
chemistry characterization techniques were distributed. FTIR chemical analysis showed proof drug incorporation into the oxide matrix because the presence of bands at 1504 cm-1, 1604 cm-1 and 1637 cm-1 reveals. this can be supported by UV-Vis results, since oxide spectrum noninheritable new options. The materials square measure mesoporous with a mean pore diameter concerning seventy eight seventy eight. In vitro drug unleash was performed by UV-Vis chemical analysis following the most optical phenomenon of MTX at 348 nm. Drug unleash was followed and monitored by sixteen days. For in vivo analysis GBM
model was performed in Wistar rats once the growth was developed a reservoir was placed by stereotactic surgery. when 3 months of growth
vaccination animals treated with MTX-SiO2 survived whereas in those untreated survival didn't exceed thirty days. [López T, Alvarez M, Arroyo S, Sánchez A, Rembao D, et al. getting of SiO2 Nanostructured Materials for native
Drug Delivery of Methotrexate]
High Impact List of Articles
-
Multidisciplinary team approach to headache care
Rigmor Højland Jensen and Annette Rasmussen
Review Article: Clinical Practice
-
Multidisciplinary team approach to headache care
Rigmor Højland Jensen and Annette Rasmussen
Review Article: Clinical Practice
-
Synovium in the pathophysiology of osteoarthritis
Roxana Monemdjou, Hassan Fahmi and Mohit Kapoor
Review Article: Clinical Practice
-
Synovium in the pathophysiology of osteoarthritis
Roxana Monemdjou, Hassan Fahmi and Mohit Kapoor
Review Article: Clinical Practice
-
Glossary: Volume 7 Issue 4
Appendices: Clinical Practice
-
Glossary: Volume 7 Issue 4
Appendices: Clinical Practice
-
The new Invisio® DUR-D ‘chip-on-the-tip’ digital flexible ureterorenoscopes: evaluation of changes in physical properties over time
Tamer El-Husseiny, Junaid Masood, Dimitrios Karamanolakis, Malcolm Birch and Noor Buchholz
Research Article: Clinical Practice
-
The new Invisio® DUR-D ‘chip-on-the-tip’ digital flexible ureterorenoscopes: evaluation of changes in physical properties over time
Tamer El-Husseiny, Junaid Masood, Dimitrios Karamanolakis, Malcolm Birch and Noor Buchholz
Research Article: Clinical Practice
-
Glossary: Volume 7 Issue 1
Appendices: Clinical Practice
-
Glossary: Volume 7 Issue 1
Appendices: Clinical Practice
-
Acknowledgment: Volume 5 Issue 1
Appendices: Clinical Practice
-
Acknowledgment: Volume 5 Issue 1
Appendices: Clinical Practice
-
Nutraceutical meal replacements: more effective than all-food diets in the treatment of obesity
Wendy M Miller, Katherine E Nori Janosz, Kerstyn C Zalesin and Peter A McCullough
Review Article: Clinical Practice
-
Nutraceutical meal replacements: more effective than all-food diets in the treatment of obesity
Wendy M Miller, Katherine E Nori Janosz, Kerstyn C Zalesin and Peter A McCullough
Review Article: Clinical Practice
-
Choice of monotherapy in newly diagnosed Type 2 diabetic patients: clinical perspective of ADOPT
Janaka Karalliedde and Robin E Buckingham
Clinical Trial Teport: Clinical Practice
-
Choice of monotherapy in newly diagnosed Type 2 diabetic patients: clinical perspective of ADOPT
Janaka Karalliedde and Robin E Buckingham
Clinical Trial Teport: Clinical Practice
-
Cilansetron: a novel, high-affinity 5-HT3 receptor antagonist for irritable bowel syndrome with diarrhea predominance
Georges Coremans
Drug Evaluation: Clinical Practice
-
Cilansetron: a novel, high-affinity 5-HT3 receptor antagonist for irritable bowel syndrome with diarrhea predominance
Georges Coremans
Drug Evaluation: Clinical Practice
Relevant Topics in Clinical